Below are 10 commonly prescribed drugs that increased in list price in the second quarter of 2019, according to GoodRx's latest quarterly report.
1. Genvisc 850 costs $159.60 per 2.5 ml syringe — a 135.1 percent increase
2. Cotempla XR costs $12.36 per 17.3 mg tablet — an 8.4 percent increase
3. Nuedextra costs $19.57 per 20 mg/ 10mg tablet — a 6.9 percent increase
4. Abilify Maintena costs $2,274.73 for one 400 mg vial — a 5 percent increase
5. Isentress costs $26.24 per 400 mg tablet — a 5 percent increase
6. Cabometyx costs $639.73 per 60 mg tablet — a 4.5 percent increase
7. Xiidra costs $8.70 per 5 percent ampule — a 3 percent increase
8. Vyvanse costs $10.13 per 40 mg tablet — a 3 percent increase
9. Gattex costs $39,271.88 per 5 mg vial — a 3 percent increase
10. Firazyr costs $3,715.83 per 30 mg/3 ml syringe — a 3 percent increase
More articles on pharmacy:
Oklahoma opioid trial wraps: 10 takeaways
Drugmaker tried to shred records before FDA inspection, agency claims
New Jersey physician, pharmacy workers charged in $10M kickback scheme